268 related articles for article (PubMed ID: 29787951)
1. Glutathione-triggered dual release of doxorubicin and camptothecin for highly efficient synergistic anticancer therapy.
Li Y; Yang H; Yao J; Yu H; Chen X; Zhang P; Xiao C
Colloids Surf B Biointerfaces; 2018 Sep; 169():273-279. PubMed ID: 29787951
[TBL] [Abstract][Full Text] [Related]
2. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
3. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
[TBL] [Abstract][Full Text] [Related]
4. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
[TBL] [Abstract][Full Text] [Related]
6. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
9. 2,2'-Dithiodisuccinic acid-stabilized polyion complex micelles for pH and reduction dual-responsive drug delivery.
Du Y; Yan W; Lian H; Xiang C; Duan L; Xiao C
J Colloid Interface Sci; 2018 Jul; 522():74-81. PubMed ID: 29579564
[TBL] [Abstract][Full Text] [Related]
10. mPEGylated solanesol micelles as redox-responsive nanocarriers with synergistic anticancer effect.
Qin B; Liu L; Wu X; Liang F; Hou T; Pan Y; Song S
Acta Biomater; 2017 Dec; 64():211-222. PubMed ID: 28963017
[TBL] [Abstract][Full Text] [Related]
11. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
12. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
Li WM; Su CW; Chen YW; Chen SY
Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
[TBL] [Abstract][Full Text] [Related]
13. Acid/GSH Dual-Responsive Endosome Escape Dual Pro-drug Micelles Targeted Synergistic Treatment for A549/ADR.
Chen H; Liu C; Yu S; Zhou H; Shafiq F; Qiao W
Langmuir; 2023 Jun; 39(22):7660-7671. PubMed ID: 37219917
[TBL] [Abstract][Full Text] [Related]
14. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
15. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
[TBL] [Abstract][Full Text] [Related]
16. Facile construction of dual-bioresponsive biodegradable micelles with superior extracellular stability and activated intracellular drug release.
Chen W; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2015 Jul; 210():125-33. PubMed ID: 25987525
[TBL] [Abstract][Full Text] [Related]
17. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.
Zhang Y; Xiao C; Li M; Chen J; Ding J; He C; Zhuang X; Chen X
Macromol Biosci; 2013 May; 13(5):584-94. PubMed ID: 23420692
[TBL] [Abstract][Full Text] [Related]
19. Reduction-sensitive micelles with sheddable PEG shells self-assembled from a Y-shaped amphiphilic polymer for intracellular doxorubicine release.
Cui C; Yu P; Wu M; Zhang Y; Liu L; Wu B; Wang CX; Zhuo RX; Huang SW
Colloids Surf B Biointerfaces; 2015 May; 129():137-45. PubMed ID: 25843367
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
